The findings reinforce the potential of BRIUMVI in improving patient outcomes for those seeking an alternative to their previous anti-CD20 therapy. Furthermore, the article in CNS DRUGS offers an ...
6h
The US Single-Cell Analysis Market is projected to reach US$2,695.3 million by 2029 from an estimated US$1,378.6 million in 2024, at a CAGR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback